Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
不同环境下宫颈癌筛查流程的多层次优化
基本信息
- 批准号:10600841
- 负责人:
- 金额:$ 98.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-10 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAffectBayesian MethodCancer Control ResearchCaringCervicalCervical Cancer ScreeningCessation of lifeClinicClinicalCollaborationsColposcopyCommunity HealthcareComplexCountyDataData SourcesDetectionDevelopmentDiagnosticDisparityEffectivenessElectronicsEligibility DeterminationEpidemiologistEthnic OriginEvaluationExhibitsFailureGeographyGoalsGuidelinesHIVHIV InfectionsHarm ReductionHealthHealth systemHealthcareHealthcare SystemsHigh-Risk CancerHospitalsHuman Papilloma Virus VaccineHuman PapillomavirusInformation SystemsInterventionKnowledgeLaboratoriesLeadLeadershipLesionLow incomeMalignant neoplasm of cervix uteriManaged CareMassachusettsMeasuresMethodsModelingObservational StudyOncogenicOrganOutcomePatientsPhysiciansPoliciesPopulationPopulation HeterogeneityPreventionPrevention strategyProcessProviderRaceResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesRiskRisk AssessmentScientistScreening for cancerService delivery modelSubgroupSystemTechnologyTestingTexasTherapeutic immunosuppressionTimeUninsuredVariantVulnerable PopulationsWashingtonWomancancer invasivenesscancer typecare systemscervical cancer preventionclinical practicecohortcolorectal cancer screeningcommunity settingdesigndisparity reductionethnic minorityexperiencefollow-uphealth care deliveryhealth care settingsimprovedinnovationlung cancer screeningmedical specialtiesmultidisciplinarymultilevel analysisnew technologynovelpatient populationpaymentpersonalized screeningpremalignantprimary care providerprogramsprovider networksracial minoritysafety netscreeningscreening guidelinessocioeconomicstooluptake
项目摘要
ABSTRACT
For more than 5 decades, the US has sought to lower cervical cancer deaths through screening; however,
disparities remain. Introduction of oncogenic human papillomavirus (HPV)-based tests and HPV vaccines have
expanded cervical cancer prevention strategies and changed screening and management guidelines. As
technology, guidelines, and policies change, our MultilEvel OpTimization of the CeRvIcal Cancer Screening
Process in Diverse Settings & Populations (METRICS) PROSPR II Research Center will elucidate multilevel
factors that hamper or facilitate the cervical cancer screening process and reduce disparities in vulnerable
populations. METRICS unites three PROSPR I Research Centers with demonstrated capability to provide
validated data for a combined cohort of ~1.2 million screened and unscreened women. Our community
settings represent 3 care delivery models—safety-net system, managed care system, and primary care
provider networks in Texas, Washington, and Massachusetts. We will collect, harmonize, and document >
10 years of high-quality, comprehensive cervical cancer screening process data at the patient, provider,
clinic, and system levels using a rich array of electronic clinical information systems and novel data sources.
Our combined cohort is socioeconomically and geographically diverse and includes vulnerable groups
such as HIV-infected and uninsured women. Our three interconnected observational projects are
designed to understand how cervical cancer screening is delivered across our spectrum of delivery models,
and how to optimize the screening process to reduce disparities. Innovative geospatial and Bayesian statistical
methods in Project 1 will better elucidate at what levels variation in screening process occurs. Project 2 will
investigate how multilevel programs and policies influence adherence to guidelines for average-risk women.
Project 3 will inform precision screening for women with altered risk. Based on our observational findings, in
years 4-5, we will design and implement pilot interventions leveraging IT-enabled tools to address key failures
in the screening process and reduce disparities. Our transdisciplinary team has epidemiologists, primary and
specialty care physicians, and intervention, implementation, and healthcare delivery experts. We are poised to
efficiently evaluate the full cervical cancer screening process and provide expertise, leadership, and resources
for cross-organ PROSPR II collaborations. Our cores and research projects will achieve our goals of
advancing understanding of screening as practiced in community settings through: (1) analysis of
multilevel observational data from our heterogeneous settings with diverse populations, (2) development and
testing of impactful interventions to optimize the screening process, and (3) application of our novel
observational projects and quality metrics to the cancer screening processes for other organs. Based on our
successful experience leading and collaborating in PROSPR I, we thoughtfully organized our four cores to
be able to launch research activities and contribute to trans-PROSPR II activities quickly and effectively.
抽象的
五十多年来,美国一直试图通过筛查来降低宫颈癌死亡率;
基于致癌人乳头瘤病毒 (HPV) 的检测和 HPV 疫苗的引入仍然存在差异。
扩大了宫颈癌预防策略并改变了筛查和管理指南。
技术、指南和政策的变化,我们对宫颈癌筛查的多层优化
不同环境和人群中的过程(指标)PROSPR II 研究中心将阐明多层次
阻碍或促进宫颈癌筛查过程并减少弱势群体差异的因素
METRICS 联合了三个具有提供能力的 PROSPR I 研究中心。
验证了我们社区约 120 万已筛查和未筛查女性的综合数据。
设置代表 3 种护理服务模式——安全网系统、管理式护理系统和初级护理
我们将收集、协调和记录德克萨斯州、华盛顿州和马萨诸塞州的提供商网络。
10 年高质量、全面的宫颈癌筛查过程数据,涉及患者、提供者、
诊所和系统级别使用丰富的电子临床信息系统和新颖的数据源。
我们的综合群体在社会经济和地理上具有多样性,并且包括弱势群体
例如感染艾滋病毒和未参保的妇女。我们的三个相互关联的观察项目是
旨在了解如何在我们的一系列交付模式中进行宫颈癌筛查,
以及如何优化筛选过程以减少创新的地理空间和贝叶斯统计。
项目 1 中的方法将更好地阐明项目 2 筛选过程中将在什么水平上发生变化。
调查多层次计划和政策如何影响对中等风险妇女的指导方针的遵守。
项目 3 将根据我们的观察结果,为具有改变风险的女性提供精确筛查。
第 4-5 年,我们将利用 IT 工具设计和实施试点干预措施来解决关键故障
我们的跨学科团队拥有流行病学家、初级专家和专家。
我们准备好了专业护理医生以及干预、实施和医疗保健提供专家。
有效评估完整的宫颈癌筛查过程并提供专业知识、领导力和资源
我们的核心和研究项目将实现我们的目标:
通过以下方式增进对社区环境中筛查的理解:(1) 分析
来自不同人群的异质环境的多层次观测数据,(2) 发展和
测试有效的干预措施以优化筛选过程,以及(3)应用我们的新颖方法
基于我们的其他器官癌症筛查过程的观察项目和质量指标。
凭借在 PROSPR I 中领导和合作的成功经验,我们精心组织了我们的四个核心
能够快速有效地开展研究活动并为跨 PROSPR II 活动做出贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Chubak其他文献
Jessica Chubak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Chubak', 18)}}的其他基金
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
- 批准号:
10477003 - 财政年份:2020
- 资助金额:
$ 98.66万 - 项目类别:
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
- 批准号:
10263878 - 财政年份:2020
- 资助金额:
$ 98.66万 - 项目类别:
Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
青少年和年轻人 (AYA) 癌症的临床护理差距和未满足的需求
- 批准号:
10658891 - 财政年份:2020
- 资助金额:
$ 98.66万 - 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
- 批准号:
10202500 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
Psychological benefits and potential pathogen transmission in hospitalized pediatric oncology patients receiving therapy dog visits: a randomized controlled trial
接受治疗犬就诊的住院儿科肿瘤患者的心理益处和潜在病原体传播:一项随机对照试验
- 批准号:
9322093 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
- 批准号:
10601364 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
ReCAPSE:SEER 增强的索赔和 PRO 的复发
- 批准号:
10428568 - 财政年份:2017
- 资助金额:
$ 98.66万 - 项目类别:
相似国自然基金
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于健康行为程式模型提升高血压患者药物依从性的干预策略构建研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Identifying and testing a tailored strategy to achieve equity in blood pressure control in PACT
确定并测试量身定制的策略,以在 PACT 中实现血压控制的公平性
- 批准号:
10538513 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别:
Examining the Effectiveness of the Early Start Denver Model in Community Programs serving Young Autistic Children
检查早期开始丹佛模式在为自闭症儿童服务的社区项目中的有效性
- 批准号:
10725999 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别:
Adapting Online Obesity Treatment for Primary Care Patients in Poverty
为贫困初级保健患者采用在线肥胖治疗
- 批准号:
10722366 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别:
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:
10824878 - 财政年份:2023
- 资助金额:
$ 98.66万 - 项目类别: